BS. Plus Mochida has a NASH patent and Amarin has a partnership with Mochida. Plus plus RIt trial has NASH data yet to be published that says while Amarin is intending to file for a NASH indication, how could thjey let GILD take it not even for a song? Ridiculous!
News 
Market Data 
Discover 
